File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S0886-3350(99)00364-8
- Scopus: eid_2-s2.0-0034017640
- PMID: 10713234
- WOS: WOS:000085768000023
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Latanoprost versus timolol gel to prevent ocular hypertension after phacoemulsification and intraocular lens implantation
Title | Latanoprost versus timolol gel to prevent ocular hypertension after phacoemulsification and intraocular lens implantation |
---|---|
Authors | |
Issue Date | 2000 |
Publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/jcrs |
Citation | Journal Of Cataract And Refractive Surgery, 2000, v. 26 n. 3, p. 386-391 How to Cite? |
Abstract | Purpose: To evaluate the efficacy of latanoprost and timolol gel in preventing ocular hypertension in the early period after phacoemulsification and posterior chamber intraocular lens (PC IOL) implantation. Setting: Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong, China. Methods: This prospective randomized double-masked clinical trial comprised patients with uncomplicated cataract having phacoemulsification with PC IOL implantation. They were randomly assigned to 1 of 3 groups: postoperative application of timolol 0.5% gel-forming solution (Timoptol-XE®) (Group 1), latanoprost 0.005% (Group 2), and control (Group 3). Intraocular pressure (IOP) was measured 2, 4, and 24 hours postoperatively. The anterior chamber was examined for the levels of cells and flare using slitlamp biomicroscopy. Results: Group 1 had a significantly greater reduction in mean IOP 2, 4, and 24 hours after phacoemulsification and PC IOL implantation than Group 3 (P < .05). There were no significant differences between Groups 2 and 3 at any interval (P > .05). No excessive postoperative anterior chamber inflammation was observed in any group. Conclusions: A single dose of latanoprost given after phacoemulsification and PC IOL implantation did not produce a significant IOP-lowering effect when compared with a control group in the first 24 hours postoperatively. A single dose of timolol gel produced a significant postoperative IOP decrease as soon as 2 hours and up to 24 hours after surgery. Timolol gel and latanoprost are safe, but timolol is more effective than latanoprost in preventing postoperative ocular hypertension. (C) 2000 ASCRS and ESCRS. |
Persistent Identifier | http://hdl.handle.net/10722/176364 |
ISSN | 2023 Impact Factor: 2.6 2023 SCImago Journal Rankings: 1.472 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lai, JSM | en_US |
dc.contributor.author | Chua, JKH | en_US |
dc.contributor.author | Leung, ATS | en_US |
dc.contributor.author | Lam, DSC | en_US |
dc.date.accessioned | 2012-11-26T09:10:50Z | - |
dc.date.available | 2012-11-26T09:10:50Z | - |
dc.date.issued | 2000 | en_US |
dc.identifier.citation | Journal Of Cataract And Refractive Surgery, 2000, v. 26 n. 3, p. 386-391 | en_US |
dc.identifier.issn | 0886-3350 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/176364 | - |
dc.description.abstract | Purpose: To evaluate the efficacy of latanoprost and timolol gel in preventing ocular hypertension in the early period after phacoemulsification and posterior chamber intraocular lens (PC IOL) implantation. Setting: Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong, China. Methods: This prospective randomized double-masked clinical trial comprised patients with uncomplicated cataract having phacoemulsification with PC IOL implantation. They were randomly assigned to 1 of 3 groups: postoperative application of timolol 0.5% gel-forming solution (Timoptol-XE®) (Group 1), latanoprost 0.005% (Group 2), and control (Group 3). Intraocular pressure (IOP) was measured 2, 4, and 24 hours postoperatively. The anterior chamber was examined for the levels of cells and flare using slitlamp biomicroscopy. Results: Group 1 had a significantly greater reduction in mean IOP 2, 4, and 24 hours after phacoemulsification and PC IOL implantation than Group 3 (P < .05). There were no significant differences between Groups 2 and 3 at any interval (P > .05). No excessive postoperative anterior chamber inflammation was observed in any group. Conclusions: A single dose of latanoprost given after phacoemulsification and PC IOL implantation did not produce a significant IOP-lowering effect when compared with a control group in the first 24 hours postoperatively. A single dose of timolol gel produced a significant postoperative IOP decrease as soon as 2 hours and up to 24 hours after surgery. Timolol gel and latanoprost are safe, but timolol is more effective than latanoprost in preventing postoperative ocular hypertension. (C) 2000 ASCRS and ESCRS. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/jcrs | en_US |
dc.relation.ispartof | Journal of Cataract and Refractive Surgery | en_US |
dc.subject.mesh | Adrenergic Beta-Antagonists - Administration & Dosage | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Anterior Chamber - Pathology | en_US |
dc.subject.mesh | Antihypertensive Agents - Administration & Dosage | en_US |
dc.subject.mesh | Cell Count | en_US |
dc.subject.mesh | Double-Blind Method | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Gels | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Intraocular Pressure - Drug Effects | en_US |
dc.subject.mesh | Lens Implantation, Intraocular - Adverse Effects | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Ocular Hypertension - Etiology - Pathology - Prevention & Control | en_US |
dc.subject.mesh | Phacoemulsification - Adverse Effects | en_US |
dc.subject.mesh | Prospective Studies | en_US |
dc.subject.mesh | Prostaglandins F, Synthetic - Administration & Dosage | en_US |
dc.subject.mesh | Timolol - Administration & Dosage | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.title | Latanoprost versus timolol gel to prevent ocular hypertension after phacoemulsification and intraocular lens implantation | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lai, JSM: laism@hku.hk | en_US |
dc.identifier.authority | Lai, JSM=rp00295 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/S0886-3350(99)00364-8 | en_US |
dc.identifier.pmid | 10713234 | - |
dc.identifier.scopus | eid_2-s2.0-0034017640 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0034017640&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 26 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.spage | 386 | en_US |
dc.identifier.epage | 391 | en_US |
dc.identifier.isi | WOS:000085768000023 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Lai, JSM=7401939748 | en_US |
dc.identifier.scopusauthorid | Chua, JKH=7005163724 | en_US |
dc.identifier.scopusauthorid | Leung, ATS=7403012621 | en_US |
dc.identifier.scopusauthorid | Lam, DSC=35500200200 | en_US |
dc.identifier.issnl | 0886-3350 | - |